Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi- infected interleukin 10-deficient mice

Infection and Immunity

Volumn 68, Issue 7, 2000, Pages 4075-4083

  Hölscher, Christoph ^a,c   Mohrs, Markus ^a,e   Dai, Wen Juan ^a,f   Köhler, Gabriele ^a   Ryffel, Bernhard ^c   Schaub, Günter A ^b   Mossmann, Horst ^a   Brombacher, Frank ^c,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; TOXIC SHOCK SYNDROME; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; FEMALE; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTRALIZATION TESTS; PARASITEMIA; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343081421     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.7.4075-4083.2000     Document Type: Article

References (45)

1. Abrahamsohn, I. A., and R. L. Coffman. 1996. Trypanosoma cruzi - IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired-immunity to infection. Exp. Parasitol. 84:231-244.
2. Bauss, F., W. Droge, and D. N. Mannel. 1987. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55:1622-1625.
3. Berg, D. J., R. Kühn, K. Rajewsky, W. Müller, S. Menon, N. Davidson, G. Grünig, and D. Rennick. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Investig. 96:2339-2347.
4. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:423-435.
5. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549-1555.
6. Brandzaeg, P., P. Ovstebo, and P. Kierulf. 1995. Bacteremia and compartmentalization of LPS in meningococcal disease, p. 219-233. In J. Levin, C. R. Alving, R. Munford, and H. Redl (ed.), Lipopolysaccharides from genes to therapy. Wiley, New York, N.Y.
7. Camargo, M. M., I. C. Almeida, M. E. Pereira, M. A. Ferguson, L. R. Travassos, and R. T. Gazzinelli. 1997. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:5890-5901.
8. Cardoni, R. L., M. I. Antunez, A. Orn, and K. O. Gronvik. 1996. T-cell receptor v-beta repertoire in the thymus and spleen of mice infected with Trypanosoma cruzi. Cell. Immunol. 169:238-245.
9. Cauwels, A., W. Fiers, and P. Brouckaert. 1996. Murine IL-12 is involved in Calmette-Guerin bacillus-induced sensitization and is by itself sufficient to sensitize mice to the lethal effects of human TNF1. J. Immunol. 156:4686-4690.
10. Cordeiro da Silva, A., E. C. Lima, M. H. Vicentelli, and P. Minoprio. 1996. V beta 6-bearing T cells are involved in resistance to Trypanosoma cruzi infection in XID mice. Int. Immunol. 8:1213-1219.
11. Dai, W. J., G. Köhler, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158:2259-2267.
12. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
13. Denis, M., and E. Ghadirian. 1993. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections. J. Immunol. 151: 5425-5430.
14. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
15. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
16. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
17. Florquin, S., Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618-2623.
18. + T cells induces functional but non-proliferative T cells in vivo. Immunology 83:333-340.
19. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157:798-805.
20. Gerard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547-550.
21. Hölscher, C., G. Köhler, U. Müller, H. Mossmann, G. A. Schaub, and F. Brombacher. 1998. Defective nitric-oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma-interferon receptor or inducible nitric-oxide synthase. Infect. Immun. 66:1208-1215.
22. Hunter, C. A., L. A. Ellis-Neyes, T. Slifer, S. Kanaly, G. Grunig, M. Fort, D. Rennick, and F. G. Araujo. 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158: 3311-3316.
23. Kühn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
24. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J. Immunol. 153:1778-1788.
25. Leist, M., F. Gantner, I. Bohlinger, G. Tiegs, P. G. Germann, and A. Wendel. 1995. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1220-1234.
26. + T cells in murine Trypanosoma cruzi infection. Int. Immunol. 6:387-392.
27. Li, C., I. Corraliza, and J. Langhorne. 1999. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. Infect. Immun. 67:4435-4442.
28. Linke, A., R. Kühn, W. Müller, N. Honarvar, C. Li, and J. Langhorne. 1996. Plasmodium chabaudi chabaudi - differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 84:253-263.
29. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
30. Marshall, A. J., and E. Y. Denkers. 1998. Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice. Infect. Immun. 66:1325-1333.
31. Mayeux, P. R. 1997. Pathobiology of lipopolysaccharide. J. Toxicol. Environ. Health 51:415-435.
32. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the super-antigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
33. Murray, P. J., and R. A. Young. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 67:3087-3095.
34. Pizzi, T., and W. H. Taliaffero. 1955. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J. Infect. Dis. 96:199-215.
35. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva, K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:3135-3140.
36. Rockett, K. A., M. M. Awburn, E. J. Rockett, and I. A. Clark. 1994. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am. J. Trop. Med. Hyg. 50:735-742.
37. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152:3514-3521.
38. Ruetten, H., C. Thiemermann, and J. R. Vane. 1996. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br. J. Pharmacol. 118:198-204.
39. Thijs, L. G., A. B. Groeneveld, and C. E. Hack. 1996. Multiple organ failure in septic shock. Curr. Top. Microhiol. Immunol. 216:209-237.
40. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. D. Fahey, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
41. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor: an updated review of its biology. Crit. Care. Med. 21:415-422.
42. Truyens, C., F. Torrico, R. Lucas, P. de Baetselier, W. A. Buurman, and Y. Carlier. 1999. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect. Immun. 67:5579-5586.
43. Vazquez-Torres, A., J. Jones-Carson, R. D. Wagner, T. Warner, and E. Balish. 1999. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 67:670-674.
44. Wagner, R. D., N. M. Maroushek, J. F. Brown, and C. J. Czuprynski. 1994. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect. Immun. 62:2345-2353.
45. Wynn, T. A., A. W. Cheever, M. E. Williams, S. Hieny, P. Caspar, R. Kühn, W. Müller, and A. Sher. 1998. IL-10 regulates liver pathology in acute murine schistosomiasis-mansoni but is not required for immune down-modulation of chronic disease. J. Immunol. 160:4473-4480.